Tumor microenvironment alters chemoresistance of hepatocellular carcinoma through CYP3A4 metabolic activity A Özkan, DL Stolley, ENK Cressman, M McMillin, S DeMorrow, ... Frontiers in oncology 11, 662135, 2021 | 32 | 2021 |
The influence of chronic liver diseases on hepatic vasculature: A liver-on-a-chip review A Özkan, D Stolley, ENK Cressman, M McMillin, S DeMorrow, ... Micromachines 11 (5), 487, 2020 | 27 | 2020 |
Vascularized hepatocellular carcinoma on a chip to control chemoresistance through cirrhosis, inflammation and metabolic activity A Özkan, DL Stolley, ENK Cressman, M McMillin, TE Yankeelov, ... Small Structures 4 (9), 2200403, 2023 | 6 | 2023 |
Combining chemistry and engineering for hepatocellular carcinoma: Nano-scale and smaller therapies DL Stolley, AC Crouch, A Özkan, EH Seeley, EM Whitley, MN Rylander, ... Pharmaceutics 12 (12), 1243, 2020 | 5 | 2020 |
Molecular, Metabolic, and Subcellular Mapping of the Tumor Immune Microenvironment via 3D Targeted and Non-Targeted Multiplex Multi-Omics Analyses S Ferri-Borgogno, JK Burks, EH Seeley, TD McKee, DL Stolley, AV Basi, ... Cancers 16 (5), 846, 2024 | 1 | 2024 |
Multilayer in vitro human skin tissue platforms for quantitative burn injury investigation S Brocklehurst, N Ghousifam, K Zuniga, D Stolley, MN Rylander Bioengineering 10 (2), 265, 2023 | 1 | 2023 |
Abstract No. 568 Volumetric CT Assessment of In Situ Induced Hepatic Lesions of an Oncopig Model D Smetanick, F Shakoor, D Stolley, M Stenkamp, S Hicks, N Fowlkes, ... Journal of Vascular and Interventional Radiology 35 (3), S209, 2024 | | 2024 |
Inflammatory Pseudotumors Induced by AdCre in Transgenic Oncopigs After In Situ Induction S Hicks, D Stolley, MS Stenkamp, D Smetanik, E Moore, W Norton, ... | | 2023 |
Cirrhosis and Inflammation Regulates CYP3A4 Mediated Chemoresistance in Vascularized Hepatocellular Carcinoma-on-a-chip A Özkan, DL Stolley, ENK Cressman, M McMillin, TE Yankeelov, ... bioRxiv, 2022.05. 04.490682, 2022 | | 2022 |
Mass Spectrometry Imaging Characterization of Ethiodized Oil, a Radiopaque Hydrophobic Multipurpose Liquid Used in Cancer Therapy S Warar, D Stolley, AC Crouch, E Cressman The University of Texas MD Anderson Cancer Center, 2021 | | 2021 |